Interprofessional Webinar Series:
Cardiac Devices and Palliative Care
This webinar is presented in collaboration with the
National Hospice and Palliative Care Organization.
Funding Disclosure: No commercial funding has been accepted for the activity.
Date and Time: February 07, 2017, 12:30 PM – 1:30 PM ET (Live)
Location: Online at https://www.mjhspalliativeinstitute.org/e-learning/
Speaker Name and Title:
Michael Mencias, MD
Senior Hospice Medical Director
MJHS Hospice and Palliative Care
Purpose: Implantable Cardioverter Defibrillators (ICDs) are widely used to reduce mortality in heart failure. Challenges for palliative care clinicians include care management associated with these devices, especially at end of life. This webinar will review the indications for implantation for these devices, discuss advance care planning, and outline the process of deactivation.
- Evaluate the current consensus statements and latest research on implantable cardioverter defibrillators in patients nearing end of life
- Discuss advance care planning and deactivation considerations
- Recognize the process and procedure for successful deactivation
Why Do I Need to Know This?
Patients with ICDs are referred with increased frequency for palliative care consultation or hospice care. Clinicians need to understand the complexity of care associated with these devices, importantly the clinical and ethical considerations, especially at end of life. This webinar will discuss how to approach the care of patients with ICDs from implantation to death.
Target Audience: palliative care specialists, pain specialists, primary care providers, nurse practitioners, registered nurses, advanced practice nurses, registered nurses with a specialty in palliative care/hospice, pharmacists, allied health professionals, fellows, residents, and medical students.
Criteria for Successful Completion:
- Attendance at entire session (mandatory for nurses)
- Submission of completed evaluation form (mandatory to receive CE/CME credit for MDs, nurses)
Continuing Education Credits: 1.0
Continuing Education Accreditation:
Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Hospice and Palliative Care Organization (NHPCO) and MJHS. NHPCO is accredited by the ACCME to provide continuing medical education for physicians.
NHPCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: NHPCO is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation.
NHPCO designates this live activity for a maximum of 1.0 contact hour. Nurses should claim only the contact hours commensurate with the extent of their participation in the activity. Accredited status by ANCC refers only to continuing nursing education and does not imply endorsement of any commercial product discussed in conjunction with this activity.
Individual: $25 (includes CME/CE certificate)
Group: $95 + $5 per CME/CE certificate
Registration fees for webinars are not refundable.
System Requirements for Computers and Mobile Devices:
Michael Mencias, MD, LLM, has no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.
Russell K. Portenoy, MD, Planner, has indicated a relationship with Pfizer Inc. and with AstraZeneca Pharmaceuticals LP for research grant support.
No other Planning Committee Member has any disclosures.
Planning Committee Members
Barbara Bouton, MA, FT
Colleen Fleming-Damon, PhDc, APRN-BC, ACHPN-BC, C.T.
Steven R. Gardner, MPA, PAHM
Myra Glajchen, DSW
Jennifer Kennedy, RN, MA, BSN, CHC
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Judith A. Skretny